Wnt signalling via the epidermal growth factor receptor: a role in breast cancer?
AUTOR(ES)
Musgrove, Elizabeth A
FONTE
BioMed Central
RESUMO
Recent data have suggested the epidermal-growth-factor receptor (EGFR) as a point of convergence for several different classes of receptor. Civenni and colleagues have now demonstrated crosstalk between Wnt signalling and the EGFR, showing that in breast epithelial cells Wnts activate downstream targets of the EGFR, including cyclin D1. Given the role of members of these pathways in the aetiology of breast cancer and as markers of outcome and potential therapeutic targets in breast cancer, this observation has a number of potential implications important for both the basic biology of breast cancer and the clinical management of the disease.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=400647Documentos Relacionados
- Tyrosine kinase signalling in breast cancer: Epidermal growth factor receptor and c-Src interactions in breast cancer
- Is there a role for Notch signalling in human breast cancer?
- Tyrosine kinase signalling in breast cancer: Epidermal growth factor receptor - convergence point for signal integration and diversification
- Epidermal Growth Factor Receptor: A Novel Target for Anticancer Treatment
- Extreme growth factor signalling can promote oestrogen receptor-α loss: therapeutic implications in breast cancer
